29/01/2026 17:41
|
Medical, Health & Aged Care
* Year-to-Date Revenue Declined by 2.8% at Constant Exchange Rate (CER), 3.3% atActual Exchange Rates (AER);Impact of VYVANSE® Generics is Tapering Off
* Core Operating Profit Declined by 3.4%...